Biotechnology Stocks I Performance Guide: Cerevel Therapeutics Holdings, Inc. (CERE)
CERE has no dividends.
Table and Chart of CERE Performance
See what a $1,000 investment in CERE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| CERE Returns | |
|---|---|
| Start Date | Nov-30-2020 |
| Start Price | $14.12 |
| End Date | May-10-2024 |
| End Price | $42.19 |
| # Prices | 43 |
| Min Date | Jan-29-2021 |
| Min Price | $12.87 |
| Max Date | Apr-30-2024 |
| Max Price | $42.71 |
| Total Return | 198.80% |
| Annualized Return | 35.73% |
| Current Value of $1,000 Purchase | $2,988 |
| Number Returns | 903 |
| Average Return | 41.24% |
| Number Profitable Returns | 634 |
| Percent Profitable Returns | 70.21% |
| Number Unprofitable Returns | 269 |
| Percent Unprofitable Returns | 29.79% |
| Profitable to Unprofitable Returns Ratio | 2.36 |
| CERE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $7,686,807,000 |
| Beta | 1.469 | Price to Sales |
| Earnings per Share | $-2.7300 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 11.28 |
| PRICE DATA | |
| 52 Week High | $43.59 |
| 52 Week Low | $19.59 |
| Analyst Target Price | $43.4 |
| 50-Day Moving Average | $42.08 |
| 200-Day Moving Average | $33.5 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -92.4% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
CERE Compare Returns with S&P 500
CERE Trendline Chart
CERE Moving Average Chart
CERE Stock Return Map - See Patterns of Gains and Losses
CERE Stock Returns/Purchase Dates